Nicole Lamanna, MD, completed her medical degree at the Albert Einstein College of Medicine in 1997 and her residency in internal medicine at NYU Medical Center in 2000. She further trained as a fellow in hemato-oncology at the Memorial Sloan-Kettering Cancer Center in 2004. Dr Lamanna currently works as an Associate Clinical Professor of Medicine at the Columbia University, Herbert Irving Comprehensive Cancer Center.
Speaking on lymphoid leukemias
Dr Lamanna is a clinical investigator with a research focus on the development of combination therapies for lymphoid leukemia, specifically chronic lymphocytic leukemia (CLL). She is working to provide safer treatment options for elderly patients with hematologic malignancies, as well as combining therapies such as chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies.